Press release
Pharmacogenomics Market Anticipates a Remarkable CAGR of 8.52% to Attain a Staggering Value of USD 8.5 Billion by 2032, Ushering in a New Era of Precision Medicine and Personalized Healthcare
Pharmacogenomics Market
The pharmacogenomics market has been experiencing steady growth, driven by advancements in genomic technologies, increasing adoption of personalized medicine, and growing awareness regarding the benefits of pharmacogenomics in optimizing drug therapy. Pharmacogenomics Market Size was valued at USD 4.1 Billion in 2022. The Pharmacogenomics market industry is projected to grow from USD 4.4 Billion in 2023 to USD 8.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.52% during the forecast period (2023 - 2032)
Pharmacogenomics, a field that combines pharmacology and genomics, has witnessed remarkable growth in recent years. This market overview delves into the current landscape of the pharmacogenomics market, covering aspects such as market size, growth rate, competitive landscape, segmentation, unique selling propositions (USPs), and regional insights.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/1177
Market Size and Growth:
The pharmacogenomics market size is influenced by various factors, including the prevalence of chronic diseases, advancements in genetic testing technologies, and regulatory initiatives promoting personalized medicine. As the demand for personalized healthcare solutions rises, the market is expected to witness significant growth in the coming years. Factors such as the declining cost of sequencing technologies and increasing investments in research and development further contribute to market expansion.
Competitive Landscape:
The pharmacogenomics market is characterized by intense competition, with several key players vying for market share. Major pharmaceutical companies, diagnostic laboratories, and biotechnology firms are actively involved in research and development activities to introduce innovative pharmacogenomic solutions.
Key Companies in the Pharmacogenomics market include.
Myriad Genetics, Inc. (U.S.)
23andMe, Inc. (U.S.)
Pathway Genomics (U.S.)
GeneTech (U.S.)
Future Science Group (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Assurex Health, Inc. (U.S.)
Bristol-Myers Squibb Company
Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Johnson & Johnson
Abbott Laboratories, Inc.
These companies focus on strategic collaborations, mergers and acquisitions, and product launches to strengthen their market position and expand their product portfolios.
Buy Now Premium Research Report:
https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1177
Market Segmentation:
The global pharmacogenomics market is segmented on the basis of technology, application, and end user.
On the basis of technology, the market is segmented into microarray, sequencing, polymerase chain reaction, and others. The sequencing segment is sub-segmented into Sanger sequencing, pyrosequencing, next-generation sequencing, and others. On the basis of application, the market is segmented into oncology, cardiology, neurological disorders, and others. The oncology segment, by technology, is sub-segmented into breast cancer, lung cancer, and others. On the basis of end users, the market is segmented into hospitals, research organizations, academic institute, and others
Browse In-depth Market Research Report (90 Pages) on Pharmacogenomics:
https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177
Market USP:
The unique selling proposition of pharmacogenomics lies in its ability to tailor drug therapy according to an individual's genetic makeup. By analyzing genetic variations that influence drug metabolism, efficacy, and safety, pharmacogenomics enables healthcare providers to optimize treatment outcomes and minimize adverse drug reactions. This personalized approach to medicine not only enhances patient care but also reduces healthcare costs associated with trial-and-error prescribing.
Regional Analysis
America dominates the global pharmacogenomics market owing to a well-developed healthcare sector. Moreover, the presence of developed economies and rising number of patients suffering from cardiovascular diseases have boosted the growth of the market in America. In 2016, according to the Centres for Diseases Control and Prevention in the U.S., heart disease was the leading cause of death for both men and women.
Europe is the second largest pharmacogenomics market, followed by the Asia Pacific region. Availability of funds for research and development along with government support within the region will drive the market growth during the forecasted period.
Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China and presence of huge opportunities in the market drives the market. According to the Indian Brand Equity Foundation in 2016, the Indian biotech industry is estimated to reach USD 100 billion by 2025 from USD 7 billion in 2015 with a CAGR of 30.46%.
On the other hand, the Middle East & Africa has the least share in the global pharmacogenomics market due to presence of poor economy and stringent government policies especially in Africa region. The majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.
Related Reports:
Pharmaceutical Cartridges Market - https://www.marketresearchfuture.com/reports/pharmaceutical-cartridges-market-11679
Food Allergy Diagnosis Treatment Market - https://www.marketresearchfuture.com/reports/food-allergy-diagnosis-treatment-market-7562
Bacterial Viral Specimen Collection Market - https://www.marketresearchfuture.com/reports/bacterial-viral-specimen-collection-market-12162
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Anticipates a Remarkable CAGR of 8.52% to Attain a Staggering Value of USD 8.5 Billion by 2032, Ushering in a New Era of Precision Medicine and Personalized Healthcare here
News-ID: 3430510 • Views: …
More Releases from Market Research Future (MRFR)
Payment Service Provider Market Projected to Hit USD 140.91 Billion at a 5.48% C …
Market Overview:
The Payment Service Provider (PSP) market has witnessed substantial growth over the past decade, driven by the explosive rise in digital commerce, mobile payments, and cross-border transactions. As businesses strive to streamline payment processes and deliver frictionless experiences to customers, the demand for robust, secure, and scalable PSP solutions has surged.
PSPs serve as intermediaries between merchants and financial institutions, enabling the acceptance of electronic payments via multiple methods…
Boundary Scan Hardware Market Poised for Growth, Reaching USD 3.16 Billion by 20 …
Market Overview:
The Boundary Scan Hardware Market has emerged as a crucial segment within the electronics testing and debugging industry, offering advanced solutions for fault detection and circuit verification in integrated circuits (ICs) and printed circuit boards (PCBs). Leveraging the IEEE 1149.1 standard, boundary scan commonly referred to as JTAG (Joint Test Action Group) provides a non-invasive and efficient testing methodology that minimizes the need for physical probes. Boundary Scan Hardware…
Metaverse for Automotive Market is Expected to Touch USD 123.51 Billion By 2034
Market Overview:
The Metaverse for Automotive Market is redefining how automakers, suppliers, and consumers interact in a digitally immersive world. With the integration of AR/VR, IoT, blockchain, and AI technologies, the automotive industry is stepping into the virtual realm to enhance everything from product design and manufacturing to marketing, sales, and customer service.
The global rise in digital transformation, coupled with increasing consumer demand for interactive and customized experiences, is fueling…
AGV Software Market to Grow at 10.82% CAGR, Hitting USD 6.46 Billion by 2034
Market Overview:
The AGV Software Market is rapidly evolving as industries shift towards intelligent automation and digital transformation in their logistics and material handling operations. AGV software acts as the brain of autonomous vehicles, enabling seamless navigation, scheduling, route optimization, fleet coordination, and task management. With the growing demand for efficient, contactless, and error-free logistics, AGV systems have found significant adoption across warehouses, manufacturing plants, ports, and healthcare facilities. AGV Software…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
